HomeGLMD • NASDAQ
add
Galmed Pharmaceuticals Ltd
Previous close
$2.94
Day range
$2.84 - $3.07
Year range
$2.56 - $23.80
Market cap
4.37M USD
Avg Volume
47.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.01M | 36.99% |
Net income | -1.91M | -29.94% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.01M | -37.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.14M | 28.75% |
Total assets | 20.95M | 18.78% |
Total liabilities | 2.51M | 20.23% |
Total equity | 18.44M | — |
Shares outstanding | 1.51M | — |
Price to book | 0.24 | — |
Return on assets | -29.32% | — |
Return on capital | -33.27% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.91M | -29.94% |
Cash from operations | -1.06M | 51.13% |
Cash from investing | 614.00K | 117.37% |
Cash from financing | 8.34M | 34.81% |
Net change in cash | 7.89M | 1,567.65% |
Free cash flow | -588.88K | 70.16% |
About
Founded
2000
Website
Employees
6
